nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data
|
Xu, Qiuyu |
|
|
39 |
3 |
p. 563-572 |
artikel |
2 |
Aloperine Alleviates Myocardial Injury Induced by Myocardial Ischemia and Reperfusion by Activating the ERK1/2/β-catenin Signaling Pathway
|
Wei, Shichao |
|
|
39 |
3 |
p. 533-551 |
artikel |
3 |
An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity
|
Liu, Sa |
|
|
39 |
3 |
p. 517-531 |
artikel |
4 |
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis
|
Elshafei, Mohamed Nabil |
|
|
39 |
3 |
p. 643-660 |
artikel |
5 |
Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data
|
Ma, Zhiqiang |
|
|
39 |
3 |
p. 677-686 |
artikel |
6 |
Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection
|
Hammer, Andreas |
|
|
39 |
3 |
p. 687-690 |
artikel |
7 |
Editorial to “A Plant-Powered Remedy: Hyperoside’s Potential Against Trastuzumab-Induced Cardiotoxicity” by Bullock et al.
|
Bullock, Zaniqua N. |
|
|
39 |
3 |
p. 477-479 |
artikel |
8 |
Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure
|
Irizarry-Caro, Jorge A. |
|
|
39 |
3 |
p. 553-562 |
artikel |
9 |
GLP-1 Receptor Agonists and Cardiac Health: Insights from a Systematic Review
|
Pedrosa, Mauricio Reis |
|
|
39 |
3 |
p. 699-700 |
artikel |
10 |
Hyperoside Protects Trastuzumab-Induced Cardiotoxicity via Activating the PI3K/Akt Signaling Pathway
|
Wei, Shanshan |
|
|
39 |
3 |
p. 481-490 |
artikel |
11 |
Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy
|
Qin, Jianning |
|
|
39 |
3 |
p. 633-641 |
artikel |
12 |
Letter to the Editor Regarding the SELECT Trial
|
Penteris, Michail |
|
|
39 |
3 |
p. 701 |
artikel |
13 |
Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases
|
Hang, Lixiao |
|
|
39 |
3 |
p. 661-676 |
artikel |
14 |
MOTS-c: Magical Molecule for Diabetic Cardiomyopathy?
|
Yerra, Veera Ganesh |
|
|
39 |
3 |
p. 473-476 |
artikel |
15 |
MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model
|
Wu, Nan |
|
|
39 |
3 |
p. 491-498 |
artikel |
16 |
Post-TEVAR Type A Aortic Dissection: Insights and Future Directions
|
Wang, Jessica K. |
|
|
39 |
3 |
p. 697-698 |
artikel |
17 |
ROS-Activated TRPM2 Channel: Calcium Homeostasis in Cardiovascular/renal System and Speculation in Cardiorenal Syndrome
|
Chen, Zihan |
|
|
39 |
3 |
p. 615-631 |
artikel |
18 |
Surgical Treatment for Type A Aortic Dissection after Endovascular Aortic Repair: A 12-year, Single-Center Study
|
Xue, Yuan |
|
|
39 |
3 |
p. 583-593 |
artikel |
19 |
The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic
|
Gu, Jun |
|
|
39 |
3 |
p. 573-581 |
artikel |
20 |
The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin
|
Basalay, M. V. |
|
|
39 |
3 |
p. 691-695 |
artikel |
21 |
Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy
|
Ruan, Yanqian |
|
|
39 |
3 |
p. 595-613 |
artikel |
22 |
The Toll-like Receptor-2/4 Antagonist, Sparstolonin B, and Inflammatory Diseases: A Literature Mining and Network Analysis
|
Yang, Rongyuan |
|
|
39 |
3 |
p. 499-515 |
artikel |